Published Erratum
doi: 10.1038/s41591-022-01693-7.
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir #
1
, Dominik Pfister #
2
, Suchira Gallage #
2
, Marta Szydlowska #
2
, Donato Inverso #
3
4
, Elena Kotsiliti
2
5
, Valentina Leone
2
6
, Moritz Peiseler
7
8
, Bas G J Surewaard
8
9
10
, Dominik Rath
11
, Adnan Ali
2
, Monika Julia Wolf
1
, Hannah Drescher
12
, Marc E Healy
1
, Daniel Dauch
13
14
, Daniela Kroy
12
, Oliver Krenkel
12
, Marlene Kohlhepp
12
, Thomas Engleitner
15
16
17
, Alexander Olkus
2
18
, Tjeerd Sijmonsma
2
, Julia Volz
19
, Carsten Deppermann
19
, David Stegner
19
, Patrick Helbling
20
, César Nombela-Arrieta
20
, Anahita Rafiei
20
, Martina Hinterleitner
13
14
, Marcel Rall
11
, Florian Baku
11
, Oliver Borst
11
, Caroline L Wilson
21
, Jack Leslie
21
, Tracy O'Connor
5
22
, Christopher J Weston
23
, Abhishek Chauhan
23
, David H Adams
23
24
, Lozan Sheriff
25
, Ana Teijeiro
26
, Marco Prinz
27
28
29
, Ruzhica Bogeska
30
31
, Natasha Anstee
30
31
, Malte N Bongers
32
, Mike Notohamiprodjo
32
, Tobias Geisler
33
, Dominic J Withers
34
35
, Jerry Ware
36
, Derek A Mann
21
, Hellmut G Augustin
3
4
, Alexandros Vegiopoulos
37
, Michael D Milsom
30
31
, Adam J Rose
38
, Patricia F Lalor
23
, Josep M Llovet
39
40
41
, Roser Pinyol
40
, Frank Tacke
12
, Roland Rad
15
16
17
, Matthias Matter
42
, Nabil Djouder
26
, Paul Kubes
7
8
9
, Percy A Knolle
22
, Kristian Unger
6
, Lars Zender
13
14
43
, Bernhard Nieswandt
19
, Meinrad Gawaz
11
, Achim Weber
44
, Mathias Heikenwalder
45
46
Affiliations
Affiliations
- 1 Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
- 2 Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
- 3 Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.
- 4 European Center of Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- 5 Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
- 6 Research Unit of Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
- 7 Calvin Phoebe & Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- 8 Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- 9 Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- 10 Department of Medical Microbiology, University Medical Center, Utrmeecht, the Netherlands.
- 11 Department of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.
- 12 Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
- 13 Department of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.
- 14 Department of Physiology I, Institute of Physiology, Eberhard Karls University Tübingen, Tübingen, Germany.
- 15 Center for Translational Cancer Research (TranslaTUM), Technische Universität München, Munich, Germany.
- 16 Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
- 17 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 18 Medical Faculty, University of Heidelberg, Heidelberg, Germany.
- 19 Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
- 20 Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
- 21 Newcastle Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
- 22 Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Munich, Germany.
- 23 Centre for Liver Research and National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Birmingham, UK.
- 24 Liver Unit, University Hospitals Birmingham NHS Trust, Birmingham, UK.
- 25 Institute for Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
- 26 Cancer Cell Biology Programme, Growth Factors, Nutrients and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.
- 27 Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
- 28 Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
- 29 Center for NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- 30 Division of Experimental Hematology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
- 31 DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH) Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
- 32 Department of Diagnostic and Interventional Radiology, University Hospital of Tübingen, Tübingen, Germany.
- 33 Department of Cardiovascular Medicine, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
- 34 Metabolic Signalling Group, MRC London Institute of Medical Sciences, London, UK.
- 35 Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
- 36 Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- 37 DKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 38 Nutrient Metabolism and Signalling Lab, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
- 39 Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Medicine, Department of Pathology, Recanati Miller Transplantation Institute), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 40 Liver Cancer Translational Research Laboratory, IDIBAPS, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalonia, Spain.
- 41 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
- 42 Institute of Pathology, University Hospital of Basel, Basel, Switzerland.
- 43 Translational Gastrointestinal Oncology Group, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 44 Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland. achim.weber@usz.ch.
- 45 Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany. heikenwaelder@helmholtz-muenchen.de.
- 46 Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany. heikenwaelder@helmholtz-muenchen.de.
# Contributed equally.
- PMID: 35181768
- DOI: 10.1038/s41591-022-01693-7
Item in Clipboard
Published Erratum
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir et al.
Nat Med.
2022 Mar.
Display options
Format
doi: 10.1038/s41591-022-01693-7.
Authors
Mohsen Malehmir #
1
, Dominik Pfister #
2
, Suchira Gallage #
2
, Marta Szydlowska #
2
, Donato Inverso #
3
4
, Elena Kotsiliti
2
5
, Valentina Leone
2
6
, Moritz Peiseler
7
8
, Bas G J Surewaard
8
9
10
, Dominik Rath
11
, Adnan Ali
2
, Monika Julia Wolf
1
, Hannah Drescher
12
, Marc E Healy
1
, Daniel Dauch
13
14
, Daniela Kroy
12
, Oliver Krenkel
12
, Marlene Kohlhepp
12
, Thomas Engleitner
15
16
17
, Alexander Olkus
2
18
, Tjeerd Sijmonsma
2
, Julia Volz
19
, Carsten Deppermann
19
, David Stegner
19
, Patrick Helbling
20
, César Nombela-Arrieta
20
, Anahita Rafiei
20
, Martina Hinterleitner
13
14
, Marcel Rall
11
, Florian Baku
11
, Oliver Borst
11
, Caroline L Wilson
21
, Jack Leslie
21
, Tracy O'Connor
5
22
, Christopher J Weston
23
, Abhishek Chauhan
23
, David H Adams
23
24
, Lozan Sheriff
25
, Ana Teijeiro
26
, Marco Prinz
27
28
29
, Ruzhica Bogeska
30
31
, Natasha Anstee
30
31
, Malte N Bongers
32
, Mike Notohamiprodjo
32
, Tobias Geisler
33
, Dominic J Withers
34
35
, Jerry Ware
36
, Derek A Mann
21
, Hellmut G Augustin
3
4
, Alexandros Vegiopoulos
37
, Michael D Milsom
30
31
, Adam J Rose
38
, Patricia F Lalor
23
, Josep M Llovet
39
40
41
, Roser Pinyol
40
, Frank Tacke
12
, Roland Rad
15
16
17
, Matthias Matter
42
, Nabil Djouder
26
, Paul Kubes
7
8
9
, Percy A Knolle
22
, Kristian Unger
6
, Lars Zender
13
14
43
, Bernhard Nieswandt
19
, Meinrad Gawaz
11
, Achim Weber
44
, Mathias Heikenwalder
45
46
Affiliations
- 1 Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
- 2 Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.
- 3 Division of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.
- 4 European Center of Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- 5 Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
- 6 Research Unit of Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
- 7 Calvin Phoebe & Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- 8 Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- 9 Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- 10 Department of Medical Microbiology, University Medical Center, Utrmeecht, the Netherlands.
- 11 Department of Cardiology and Circulatory Diseases, Internal Medicine Clinic III, Eberhard Karls University Tübingen, Tübingen, Germany.
- 12 Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
- 13 Department of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.
- 14 Department of Physiology I, Institute of Physiology, Eberhard Karls University Tübingen, Tübingen, Germany.
- 15 Center for Translational Cancer Research (TranslaTUM), Technische Universität München, Munich, Germany.
- 16 Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
- 17 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 18 Medical Faculty, University of Heidelberg, Heidelberg, Germany.
- 19 Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
- 20 Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
- 21 Newcastle Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
- 22 Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Munich, Germany.
- 23 Centre for Liver Research and National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Birmingham, UK.
- 24 Liver Unit, University Hospitals Birmingham NHS Trust, Birmingham, UK.
- 25 Institute for Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
- 26 Cancer Cell Biology Programme, Growth Factors, Nutrients and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.
- 27 Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
- 28 Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
- 29 Center for NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- 30 Division of Experimental Hematology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
- 31 DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH) Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
- 32 Department of Diagnostic and Interventional Radiology, University Hospital of Tübingen, Tübingen, Germany.
- 33 Department of Cardiovascular Medicine, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
- 34 Metabolic Signalling Group, MRC London Institute of Medical Sciences, London, UK.
- 35 Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
- 36 Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- 37 DKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 38 Nutrient Metabolism and Signalling Lab, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, and Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
- 39 Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Medicine, Department of Pathology, Recanati Miller Transplantation Institute), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 40 Liver Cancer Translational Research Laboratory, IDIBAPS, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalonia, Spain.
- 41 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
- 42 Institute of Pathology, University Hospital of Basel, Basel, Switzerland.
- 43 Translational Gastrointestinal Oncology Group, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 44 Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland. achim.weber@usz.ch.
- 45 Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany. heikenwaelder@helmholtz-muenchen.de.
- 46 Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany. heikenwaelder@helmholtz-muenchen.de.
# Contributed equally.
- PMID: 35181768
- DOI: 10.1038/s41591-022-01693-7
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.Malehmir M, Pfister D, Gallage S, Szydlowska M, Inverso D, Kotsiliti E, Leone V, Peiseler M, Surewaard BGJ, Rath D, Ali A, Wolf MJ, Drescher H, Healy ME, Dauch D, Kroy D, Krenkel O, Kohlhepp M, Engleitner T, Olkus A, Sijmonsma T, Volz J, Deppermann C, Stegner D, Helbling P, Nombela-Arrieta C, Rafiei A, Hinterleitner M, Rall M, Baku F, Borst O, Wilson CL, Leslie J, O'Connor T, Weston CJ, Chauhan A, Adams DH, Sheriff L, Teijeiro A, Prinz M, Bogeska R, Anstee N, Bongers MN, Notohamiprodjo M, Geisler T, Withers DJ, Ware J, Mann DA, Augustin HG, Vegiopoulos A, Milsom MD, Rose AJ, Lalor PF, Llovet JM, Pinyol R, Tacke F, Rad R, Matter M, Djouder N, Kubes P, Knolle PA, Unger K, Zender L, Nieswandt B, Gawaz M, Weber A, Heikenwalder M. Malehmir M, et al. Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1. Nat Med. 2019. PMID: 30936549 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
